Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma
Open Access
- 8 October 2020
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 61, 103056
- https://doi.org/10.1016/j.ebiom.2020.103056
Abstract
No abstract availableKeywords
Funding Information
- NSFC-Liaoning Joint Fund Key Program (U1608281)
- National Natural Science Foundation of China (81601370)
This publication has 43 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cellsNeuro-Oncology, 2011
- Cell cycle-regulated expression and subcellular localization of a kinesin-8 member human KIF18BGene, 2010
- Radiation countermeasure agents: an updateExpert Opinion on Therapeutic Patents, 2009
- The DNA repair complex DNA-PK, a pharmacological target in cancer chemotherapy and radiotherapyPathologie Biologie, 2006
- Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage CheckpointsAnnual Review of Biochemistry, 2004
- Systematic analysis of the TGF-β/Smad signalling pathway in the rhabdomyosarcoma cell line RDInternational Journal of Experimental Pathology, 2003
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002